Log In
Print this Print this

MTL-CEBPA (formerly MTL-501)

  Manage Alerts
Collapse Summary General Information
Company MiNA Therapeutics Ltd.
DescriptionSmall activating RNA (saRNA) targeting the CEBPA gene formulated into a Smarticles liposomal nanoparticle
Molecular Target CCAAT enhancer binding protein alpha (CEBPA)
Mechanism of ActionGene therapy
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPhase I
Standard IndicationLiver cancer
Indication DetailsTreat advanced primary or metastatic liver cancer; Treat hepatocellular carcinoma (HCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today